Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (4567)	1/19/2006 9:37:52 AM
From: sjemmeri	of 4974

1/18/2006 OMRI Biotechnology concern Omrix files for IPO Omrix Biopharmaceuticals, a developer of biosurgical and passive immunotherapy products, registered for an initial public offering Wednesday evening. For the twelve-month period ended September 2005, the NY based company generated nearly $25 million in sales with a gross margin of 21.3%. UBS Investment Bank and CIBC World Markets head the list of underwriters on the deal. Terms and timing have yet to be decided.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next